During the last session, Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares were 56733.0, with the beta value of the company hitting 1.30. At the end of the trading day, the stock’s price was $4.57, reflecting an intraday gain of 3.39% or $0.15. The 52-week high for the BLRX share is $35.60, that puts it down -678.99 from that peak though still a striking 49.67% gain since the share price plummeted to a 52-week low of $2.30. The company’s market capitalization is $19.47M, and the average trade volume was 661.34K shares over the past three months.
Bioline Rx Ltd ADR (BLRX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BLRX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Bioline Rx Ltd ADR (NASDAQ:BLRX) trade information
Bioline Rx Ltd ADR (BLRX) registered a 3.39% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.39% in intraday trading to $4.57, hitting a weekly high. The stock’s 5-day price performance is -15.99%, and it has moved by 39.79% in 30 days. Based on these gigs, the overall price performance for the year is -82.89%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 46.38%. While earnings are projected to return 96.78% in 2025, the next five years will return 64.43% per annum.
BLRX Dividends
Bioline Rx Ltd ADR is due to release its next quarterly earnings on 2024-Nov-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Bioline Rx Ltd ADR (NASDAQ:BLRX)’s Major holders
Bioline Rx Ltd ADR insiders own 4.08% of total outstanding shares while institutional holders control 0.22%, with the float percentage being 0.23%. MORGAN STANLEY is the largest shareholder of the company, while 12.0 institutions own stock in it. As of 2024-06-30, the company held over 68437.0 shares (or 0.0857% of all shares), a total value of $39002.0 in shares.
The next largest institutional holding, with 1.95 million shares, is of ALYESKA INVESTMENT GROUP, L.P.’s that is approximately 0.0041% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.11 million.
